163 related articles for article (PubMed ID: 6364038)
41. Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment.
Straetmans N; Ma DD; Herman P; Zenebergh A; Chang A; Deneys V; De Bruyère M; Ferrant A
Bone Marrow Transplant; 1995 Mar; 15(3):421-8. PubMed ID: 7599567
[TBL] [Abstract][Full Text] [Related]
42. The feasibility of peripheral blood stem cell collection for autograft following failure in bone marrow aspiration.
Lefrère F; Hermine O; Audat F; Buzyn A; Cavazzana-Calvo M; Boccaccio C; Varet B
Hematol Cell Ther; 1998 Jun; 40(3):133-7. PubMed ID: 9698222
[TBL] [Abstract][Full Text] [Related]
43. High-dose AMSA and autologous bone marrow transplantation in relapsed acute leukemia.
Zander AR; Vellekoop L; Dicke KA; Keating MJ; McCredie KB; Legha SS; Spitzer G; Verma D; Bodey GP
Cancer Treat Rep; 1982 Nov; 66(11):1991-2. PubMed ID: 6754077
[No Abstract] [Full Text] [Related]
44. Peripheral blood progenitor cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia.
Löwenberg B; van Putten WL; Ferrant A; Ossenkoppele G; Vellenga E; Verdonck LF; Gratwohl A; Boogaerts MA
Stem Cells; 1997; 15 Suppl 1():177-80; discussion 181. PubMed ID: 9368339
[TBL] [Abstract][Full Text] [Related]
45. Current progress in the treatment of adult acute leukemia in Japan.
Ohno R
Jpn J Clin Oncol; 1993 Apr; 23(2):85-97. PubMed ID: 7685836
[No Abstract] [Full Text] [Related]
46. Oupatient programs of myeloablative chemotherapy, autologous and allogeneic bone marrow transplantation.
Ruiz Arguelles GJ
Haematologica; 2000 Dec; 85(12):1233-4. PubMed ID: 11114127
[No Abstract] [Full Text] [Related]
47. [Bone marrow transplantation in humans. I. Transplantation in acute and chronic leukemia].
Izzi T; Gale PG; Lucarelli G
Recenti Prog Med; 1982 Feb; 72(2):213-28. PubMed ID: 7048459
[No Abstract] [Full Text] [Related]
48. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
Jiang R; Bony V; Lopez M
Prog Clin Biol Res; 1994; 389():23-9. PubMed ID: 7700906
[No Abstract] [Full Text] [Related]
49. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
[TBL] [Abstract][Full Text] [Related]
50. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926
[No Abstract] [Full Text] [Related]
51. [Results and prospects of treatment of various hematologic tumors].
Vorob'ev AI
Ter Arkh; 1981; 53(1):23-9. PubMed ID: 7013139
[No Abstract] [Full Text] [Related]
52. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
Richel DJ; Baars JW; Wijngaarden MJ; van der Schoot CE; Vlasveld LT; Rodenhuis S
Ned Tijdschr Geneeskd; 1993 Jan; 137(5):245-50. PubMed ID: 7679478
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of colony-forming cells from bone marrow of leukemic patients by 3-oxauracil.
Reiner P; Mardiak J; Reinerová M; Ujházy V
Neoplasma; 1981; 28(5):533-9. PubMed ID: 6947140
[TBL] [Abstract][Full Text] [Related]
54. Clinical use of hematopoietic growth factors.
Löwenberg B; Dale DC; Sheridan WP
Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
[No Abstract] [Full Text] [Related]
55. Autologous marrow transplantation: current status and future directions.
Vogler WR; Winton EF
Prog Clin Cancer; 1982; 8():45-56. PubMed ID: 6130569
[No Abstract] [Full Text] [Related]
56. Current status of syngeneic marrow transplantation and its relevance to autografting.
Fefer A
Clin Haematol; 1986 Feb; 15(1):49-65. PubMed ID: 3516493
[No Abstract] [Full Text] [Related]
57. Autologous bone marrow transplantation in hematological malignancies.
Gorin NC
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):1-9. PubMed ID: 6363092
[No Abstract] [Full Text] [Related]
58. The myeloid progenitor cell--its value in predicting hematopoietic recovery after autologous bone marrow transplantation.
Spitzer G; Verma DS; Fisher R; Zander A; Vellekoop L; Litam J; McCredie KB; Dicke KA
Blood; 1980 Feb; 55(2):317-23. PubMed ID: 6243501
[No Abstract] [Full Text] [Related]
59. [Autologous bone marrow transplantation without cryopreservation after megadoses of oncolytic chemotherapy. Pilot study in 18 cases].
Carella AM; Santini G; Frassoni F; Giordano D; Congiu A; Nati S; Risso M; Cerri R; Occhini D; Damasio E
Haematologica; 1983; 68(5):620-37. PubMed ID: 6315548
[No Abstract] [Full Text] [Related]
60. Cryopreservation of marrow cells for ABMT. Is there any effect on the harvested leukaemic cells?
Alessandrino EP; Bernasconi P; Lazzarino M; Castelli G; Bonfichi M; Caldera D; Colombo A; Boni M; Bernasconi C
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():81-4. PubMed ID: 2697444
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
